Cell Communication and Signaling,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: Jan. 12, 2024
Abstract
Prostate
cancer,
as
one
of
the
most
prevalent
malignancies
in
males,
exhibits
an
approximate
5-year
survival
rate
95%
advanced
stages.
A
myriad
molecular
events
and
mutations,
including
accumulation
oncometabolites,
underpin
genesis
progression
this
cancer
type.
Despite
growing
research
demonstrating
pivotal
role
oncometabolites
supporting
various
cancers,
prostate
root
causes
their
accumulation,
especially
absence
enzymatic
remain
elusive.
Consequently,
identifying
a
tangible
therapeutic
target
poses
formidable
challenge.
In
review,
we
aim
to
delve
deeper
into
implications
oncometabolite
cancer.
We
center
our
focus
on
consequential
epigenetic
alterations
impacts
stem
cells,
with
ultimate
goal
outlining
novel
strategies.
Graphical
International Journal of Molecular Sciences,
Journal Year:
2021,
Volume and Issue:
22(12), P. 6262 - 6262
Published: June 10, 2021
Colorectal
carcinoma
(CRC)
is
one
of
the
most
frequently
diagnosed
carcinomas
and
leading
causes
cancer-related
death
worldwide.
Metabolic
reprogramming,
a
hallmark
cancer,
closely
related
to
initiation
progression
carcinomas,
including
CRC.
Accumulating
evidence
shows
that
activation
oncogenic
pathways
loss
tumor
suppressor
genes
regulate
metabolic
reprogramming
mainly
involved
in
glycolysis,
glutaminolysis,
one-carbon
metabolism
lipid
metabolism.
The
abnormal
program
provides
cells
with
abundant
energy,
nutrients
redox
requirements
support
their
malignant
growth
metastasis,
which
accompanied
by
impaired
flexibility
microenvironment
(TME)
dysbiosis
gut
microbiota.
crosstalk
between
cells,
components
TME
intestinal
microbiota
further
facilitates
CRC
cell
proliferation,
invasion
metastasis
leads
therapy
resistance.
Hence,
target
dysregulated
metabolism,
microbiota,
novel
preventive
therapeutic
applications
are
required.
In
this
review,
dysregulation
programs,
molecular
pathways,
addressed.
Possible
strategies,
inhibition
immune
CRC,
as
well
modulation
aberrant
discussed.
Journal of Hematology & Oncology,
Journal Year:
2021,
Volume and Issue:
14(1)
Published: Nov. 27, 2021
Abstract
Background
Immune
checkpoint
blockade
resistance
narrows
the
efficacy
of
cancer
immunotherapies,
but
underlying
mechanism
remains
elusive.
Delineating
inherent
mechanisms
anti-PD1
is
important
to
improve
outcome
patients
with
advanced
HCC.
Method
The
level
cricTMEM181
was
measured
in
HCC
therapy
by
RNA
sequencing
and
then
confirmed
qPCR
Sanger
sequencing.
status
tumor
microenvironment
or
mice
models
evaluated
flow
cytometry
IHC.
Exosomes
from
cell
lines
were
isolated
ultracentrifugation,
their
internalization
macrophage
immunofluorescence.
HCC-derived
exosomal
circTMEM181
SILAC,
FISH
immunoprecipitation.
ATP–ADO
pathway
amplified
HCC–macrophage
interaction
through
ATP,
AMP
ADO
measurement
macrophage-specific
CD39
knockout
mice.
role
its
clinical
significance
also
determined
our
retrospective
cohorts.
Results
Here,
we
found
that
elevated
hepatocellular
carcinoma
(HCC)
responding
poorly
a
poor
prognosis
after
operation.
Moreover,
high
favored
immunosuppressive
endowed
Mechanistically,
sponged
miR-488-3p
upregulated
expression
macrophages.
Using
pharmacologic
approaches,
revealed
novel
mode
We
discovered
cell-specific
macrophages
CD73
cells
synergistically
activated
eATP–adenosine
produced
more
adenosine,
thereby
impairing
CD8
+
T
function
driving
resistance.
Conclusion
In
summary,
contributes
immunosuppression
elevating
expression,
inhibiting
ATP–adenosine
targeting
on
can
rescue
Graphical
Science Immunology,
Journal Year:
2023,
Volume and Issue:
8(82)
Published: April 14, 2023
Chimeric
antigen
receptor
(CAR)
T
cells
have
achieved
true
clinical
success
in
treating
hematological
malignancy
patients,
laying
the
foundation
of
CAR
as
a
new
pillar
cancer
therapy.
Although
these
promising
effects
generated
strong
interest
expanding
treatment
to
solid
tumors,
reproducible
demonstration
efficacy
setting
tumors
has
remained
challenging
date.
Here,
we
review
how
metabolic
stress
and
signaling
tumor
microenvironment,
including
intrinsic
determinants
response
cell
therapy
extrinsic
obstacles,
restrict
treatment.
In
addition,
discuss
use
novel
approaches
target
rewire
programming
for
manufacturing.
Last,
summarize
strategies
that
aim
improve
adaptability
enhance
their
potency
mounting
antitumor
responses
survival
within
microenvironment.
Pharmacological Reports,
Journal Year:
2023,
Volume and Issue:
75(4), P. 876 - 890
Published: June 19, 2023
Abstract
Although
Warburg's
discovery
of
intensive
glucose
uptake
by
tumors,
followed
lactate
fermentation
in
oxygen
presence
was
made
a
century
ago,
it
is
still
an
area
intense
research
and
development
new
hypotheses
that,
layer
layer,
unravel
the
complexities
neoplastic
transformation.
This
seemingly
simple
metabolic
reprogramming
cancer
cells
reveals
intriguing,
multi-faceted
nature
that
may
link
various
phenomena
including
cell
signaling,
proliferation,
ROS
generation,
energy
supply,
macromolecules
synthesis/biosynthetic
precursor
immunosuppression,
or
cooperation
cancerous
with
cancer-associated
fibroblasts
(CAFs),
known
as
reversed
Warburg
effect.
According
to
current
perception
causes
consequences
effect,
PI3K/Akt/mTOR
are
main
signaling
pathways
concert
transcription
factors
HIF-1,
p53,
c-Myc,
modulate
activity/expression
key
regulatory
enzymes,
PKM2,
PDK1
tune
most
optimal
setting
for
cell.
turn
secures
adequate
levels
biosynthetic
precursors,
NADPH,
NAD
+
,
rapid
ATP
production
meet
increased
demands
intensively
proliferating
tumor
cells.
The
end-product
“aerobic
glycolysis”,
lactate,
oncometabolite,
provide
fuel
neighboring
cells,
facilitate
metastasis
immunosuppression
together
enabling
progression.
importance
possible
applicability
presented
issue
best
illustrated
numerous
trials
agents
targeting
constituting
promising
strategy
future
anti-cancer
regimens.
In
this
review,
we
present
aspects
multifactorial
phenomenon,
depicting
mechanisms
benefits
behind
also
pointing
selected
field
anticancer
therapy.
Journal of Experimental & Clinical Cancer Research,
Journal Year:
2023,
Volume and Issue:
42(1)
Published: Feb. 17, 2023
Circular
RNAs
(circRNAs)
have
important
regulatory
functions
in
cancer,
but
the
role
of
circRNAs
tumor
microenvironment
(TME)
remains
unclear.
Moreover,
we
also
explore
effects
si-circRNAs
loaded
nanoparticles
as
therapeutic
agent
for
anti-tumor
vivo.We
conducted
bioinformatics
analysis,
qRT-PCR,
EdU
assays,
Transwell
co-culture
system
and
multiple
orthotopic
xenograft
models
to
investigate
expression
function
circRNAs.
Additionally,
PLGA-based
with
were
used
evaluate
potential
nanotherapeutic
strategy
response.We
identified
oncogene
SERPINE2
derived
circRNA,
named
cSERPINE2,
which
was
notably
elevated
breast
cancer
closely
related
poor
clinical
outcome.
Functionally,
exosomal
cSERPINE2
shuttled
associated
macrophages
(TAMs)
enhanced
secretion
Interleukin-6
(IL-6),
leading
increased
proliferation
invasion
cells.
Furthermore,
IL-6
turn
EIF4A3
CCL2
levels
within
cells
a
positive
feedback
mechanism,
further
enhancing
biogenesis
promoting
recruitment
TAMs.
More
importantly,
developed
nanoparticle
si-cSERPINE2,
effectively
attenuated
progression
vivo.Our
study
illustrates
novel
mechanism
that
mediates
loop
between
TAMs
promote
progression,
may
serve
promising
treatment
cancer.
Nutrient
stress
in
the
tumor
microenvironment
requires
cancer
cells
to
adopt
adaptive
metabolic
programs
for
survival
and
proliferation.
Therefore,
knowledge
of
microenvironmental
nutrient
levels
how
cope
with
such
nutrition
is
critical
understand
metabolism
underpinning
cell
biology.
Previously,
we
performed
quantitative
metabolomics
interstitial
fluid
(the
local
perfusate)
murine
pancreatic
ductal
adenocarcinoma
(PDAC)
tumors
comprehensively
characterize
availability
these
tumors.
Here,
develop